NCT03753685 2025-07-23X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain MetastasesFudan UniversityPhase 2 Active not recruiting27 enrolled
NCT00390806 2014-01-20Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung CancerGlaxoSmithKlinePhase 3 Completed472 enrolled 35 charts